Board Meeting5 Aug 2026, 07:02 pm
Akums Drugs Board Meeting on Aug 8 to Approve Un-audited Results
AI Summary
Akums Drugs and Pharmaceuticals Ltd has announced that its Board of Directors will convene on August 8, 2026. The primary agenda for this meeting is to consider and approve the un-audited standalone and consolidated financial results for the quarter ended June 30, 2026. Additionally, the company stated that the trading window, which is currently closed, will reopen 48 hours after the declaration of these financial results, in compliance with SEBI regulations.
Key Highlights
- Board meeting scheduled for August 8, 2026.
- To approve un-audited financial results for Q1 FY27.
- Results will be both standalone and consolidated.
- Trading window to reopen post-results declaration.
Price Impact
More from AKUMS